Tyrosine Kinase Inhibition in a Lung Adenocarcinoma Patient With Dual G719S and S768I EGFR Mutations

被引：1
|
作者：
Zaemes, Jacob [1 ]
Hall, Richard D. [1 ]
Gentzler, Ryan D. [1 ]
机构：
[1] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2018.03.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E136 / E137
页数：3
相关论文
共 50 条
  • [1] Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations
    Nasu, Shingo
    Shiroyama, Takayuki
    Morita, Satomu
    Takata, So
    Takada, Himmune
    Masuhiro, Kentaro
    Tanaka, Ayako
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Hirashima, Tomonori
    [J]. INTERNAL MEDICINE, 2018, 57 (24) : 3643 - 3645
  • [2] The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I Mutations
    Watanabe, Masahiro
    Oizumi, Satoshi
    Kiuchi, Shizuka
    Yamada, Noriyuki
    Yokouchi, Hiroshi
    Fukumoto, Shinichi
    Harada, Masao
    [J]. INTERNAL MEDICINE, 2018, 57 (07) : 993 - 996
  • [3] Osimertinib Did Not Respond to a Pulmonary Adenocarcinoma with Triple Mutations of Epidermal Growth Factor Receptor, G719S, T790M and S768I
    Minami, Seigo
    Ihara, Shouichi
    Tanaka, Tsunehiro
    Okada, Hideyasu
    Hashimoto, Kazuki
    Komuta, Kiyoshi
    [J]. CASE REPORTS IN ONCOLOGY, 2019, 12 (01): : 178 - 182
  • [4] The Effectiveness of Osimertinib in a NSCLC Patient with Complex Uncommon EGFR Mutations of G719X and S768I: A Case Report
    Ma, K.
    Wang, X.
    Cai, Y.
    Xu, Y.
    Guo, Y.
    Sun, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S935 - S935
  • [5] Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X+S768I mutations in non-small cell lung cancer: An in silico approaches
    Wang, Jun-Ling
    Liu, Ming-Sheng
    Fu, Yu-Dong
    Kan, Qiang-Bo
    Li, Chun-Yan
    Ma, Rong
    Fang, Zhe-Wei
    Liu, Hong-Xia
    Li, Meng-Xian
    Lv, Jia-Ling
    Sang, Peng
    Zhang, Chao
    Li, Hong-Wei
    [J]. OPEN LIFE SCIENCES, 2023, 18 (01):
  • [6] Gefitinib-induced hemorrhagic cystitis and inflammatory contracted bladder in a patient with advanced lung adenocarcinoma harboring compound epidermal growth factor receptor G719S and S768I missense mutations: a case report
    Bai, Xueli
    Cheng, Jiande
    Zhao, Lifen
    Cheng, Mengyu
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (14)
  • [7] Response to: Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations
    Citarella, Fabrizio
    Russano, Marco
    Perrone, Giuseppe
    Vincenzi, Bruno
    Tonini, Giuseppe
    Santini, Daniele
    [J]. THORACIC CANCER, 2021, 12 (11) : 1791 - 1792
  • [8] A rare case of double primary lung adenocarcinomas with uncommon complex EGFR G719X and S768I mutations and pleomorphic carcinoma
    Morimoto, Toshiki
    Yamasaki, Kei
    Shingu, Tatsuya
    Higashi, Yasuyuki
    Maeda, Yukinori
    Uryu, Takumu
    Kubo, Naoto
    Kawaguchi, Takako
    Nishida, Chinatsu
    Yatera, Kazuhiro
    [J]. THORACIC CANCER, 2023, 14 (29) : 2981 - 2984
  • [9] Primary Resistance to Afatinib in a Patient with Lung Adenocarcinoma Harboring Uncommon EGFR Mutations: S768I and V769L
    Niogret, Julie
    Coudert, Bruno
    Boidot, Romain
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : E113 - E113
  • [10] Responsiveness to Full-Dose Afatinib in a Patient With Lung Adenocarcinoma Harboring EGFR S768I and V769L Mutations
    Zhang, Hao
    Shao, Yang W.
    Xia, Yang
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (02) : E25 - E27
12345